Pulmonary

What Makes Us Different

Comprehensive Pediatric Pulmonology Care

Pediatric Pulmonology subspecialists provide comprehensive evaluation and treatment for children with conditions such as cystic fibrosis, chronic cough, asthma & other causes of wheezing, aspiration/dysphagia-related lung disease, chronic lung disease of prematurity (bronchopulmonary dysplasia) and a wide variety of other disorders. The Pediatric Pulmonary group, consisting of eight pediatric pulmonologists, Pediatric Pulmonary Medicine fellows, advanced practice nurses, specialty nurses, respiratory therapists, social workers, nutrition specialists and others, employs a team approach; providing full-service inpatient and outpatient care.

Advanced Diagnostic and Treatment Services

Services offered by the Pediatric Pulmonary Division include state-of-the-art bronchoscopy, outstanding PFT laboratories and Respiratory Care services, a state-of-the-art infant PFT laboratory, a fully-accredited Pediatrics Sleep Center, the only accredited Cystic Fibrosis Center in the state, the Arkansas Center for Respiratory Technology Dependent Children (ACRTDC), and specialized clinics for asthma, chronic lung disease of infancy (BPD) and pulmonary complications of neurological and neuromuscular disorders. The ACRTDC program provides state-of-the-art-services for children requiring respiratory support at home such as a ventilator, airway clearance devices and/or have a tracheostomy. Pediatric Pulmonary physicians are an integral part of the Pediatric Sleep Disorders Center, which is one of the only 14 fully accredited Pediatric Sleep Medicine Centers in the USA.

Research and Innovation

Basic, applied and clinical research programs within the Pediatric Pulmonary Division focus on multiple areas including research in childhood sleep disorders, infant apnea, infant pulmonary function testing, asthma, aerosol medicine, cystic fibrosis, control of breathing and postnatal development of oxygen sensing.

2024 Outcomes

By the Numbers

• 100% of children ages 7-17 met treatment guidelines for CF patients
• 457 unique patients with a diagnosis of rare lung disease were seen at least once in the inpatient or outpatient setting by the pediatric pulmonology program in the last year
• 99% of eligible patients with neuromuscular weakness disorders had pulmonary function testing in the last 12 months
• 100.3% is the median FEV1 for CF patients ages 6-12 years of age
• 104.5% is the median FEV1 for CF patients ages 13-17 years of age

Awards and Achievements

• Ranked number 29 by U.S. News & World Report
• Awarded five-year Cystic Fibrosis (CF) Center reaccreditation by the National Cystic Fibrosis Foundation
• One of the nation's largest pediatric respiratory therapy departments
• APEX Recognition by the American Association for Respiratory Care
• Creation of emergency-use albuterol action plans for school nurses across Arkansas, with support from the Arkansas Chapter of the American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP) and Arkansas Medical Society (AMS)

Your Visit

What Makes Us Different

Comprehensive Pediatric Pulmonology Care

Pediatric Pulmonology subspecialists provide comprehensive evaluation and treatment for children with conditions such as cystic fibrosis, chronic cough, asthma & other causes of wheezing, aspiration/dysphagia-related lung disease, chronic lung disease of prematurity (bronchopulmonary dysplasia) and a wide variety of other disorders. The Pediatric Pulmonary group, consisting of eight pediatric pulmonologists, Pediatric Pulmonary Medicine fellows, advanced practice nurses, specialty nurses, respiratory therapists, social workers, nutrition specialists and others, employs a team approach; providing full-service inpatient and outpatient care.

Advanced Diagnostic and Treatment Services

Services offered by the Pediatric Pulmonary Division include state-of-the-art bronchoscopy, outstanding PFT laboratories and Respiratory Care services, a state-of-the-art infant PFT laboratory, a fully-accredited Pediatrics Sleep Center, the only accredited Cystic Fibrosis Center in the state, the Arkansas Center for Respiratory Technology Dependent Children (ACRTDC), and specialized clinics for asthma, chronic lung disease of infancy (BPD) and pulmonary complications of neurological and neuromuscular disorders. The ACRTDC program provides state-of-the-art-services for children requiring respiratory support at home such as a ventilator, airway clearance devices and/or have a tracheostomy. Pediatric Pulmonary physicians are an integral part of the Pediatric Sleep Disorders Center, which is one of the only 14 fully accredited Pediatric Sleep Medicine Centers in the USA.

Research and Innovation

Basic, applied and clinical research programs within the Pediatric Pulmonary Division focus on multiple areas including research in childhood sleep disorders, infant apnea, infant pulmonary function testing, asthma, aerosol medicine, cystic fibrosis, control of breathing and postnatal development of oxygen sensing.

2024 Outcomes

By the Numbers

• 100% of children ages 7-17 met treatment guidelines for CF patients
• 457 unique patients with a diagnosis of rare lung disease were seen at least once in the inpatient or outpatient setting by the pediatric pulmonology program in the last year
• 99% of eligible patients with neuromuscular weakness disorders had pulmonary function testing in the last 12 months
• 100.3% is the median FEV1 for CF patients ages 6-12 years of age
• 104.5% is the median FEV1 for CF patients ages 13-17 years of age

Awards and Achievements

• Ranked number 29 by U.S. News & World Report
• Awarded five-year Cystic Fibrosis (CF) Center reaccreditation by the National Cystic Fibrosis Foundation
• One of the nation's largest pediatric respiratory therapy departments
• APEX Recognition by the American Association for Respiratory Care
• Creation of emergency-use albuterol action plans for school nurses across Arkansas, with support from the Arkansas Chapter of the American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP) and Arkansas Medical Society (AMS)

Your Visit

What Makes Us Different

Comprehensive Pediatric Pulmonology Care

Pediatric Pulmonology subspecialists provide comprehensive evaluation and treatment for children with conditions such as cystic fibrosis, chronic cough, asthma & other causes of wheezing, aspiration/dysphagia-related lung disease, chronic lung disease of prematurity (bronchopulmonary dysplasia) and a wide variety of other disorders. The Pediatric Pulmonary group, consisting of eight pediatric pulmonologists, Pediatric Pulmonary Medicine fellows, advanced practice nurses, specialty nurses, respiratory therapists, social workers, nutrition specialists and others, employs a team approach; providing full-service inpatient and outpatient care.

Advanced Diagnostic and Treatment Services

Services offered by the Pediatric Pulmonary Division include state-of-the-art bronchoscopy, outstanding PFT laboratories and Respiratory Care services, a state-of-the-art infant PFT laboratory, a fully-accredited Pediatrics Sleep Center, the only accredited Cystic Fibrosis Center in the state, the Arkansas Center for Respiratory Technology Dependent Children (ACRTDC), and specialized clinics for asthma, chronic lung disease of infancy (BPD) and pulmonary complications of neurological and neuromuscular disorders. The ACRTDC program provides state-of-the-art-services for children requiring respiratory support at home such as a ventilator, airway clearance devices and/or have a tracheostomy. Pediatric Pulmonary physicians are an integral part of the Pediatric Sleep Disorders Center, which is one of the only 14 fully accredited Pediatric Sleep Medicine Centers in the USA.

Research and Innovation

Basic, applied and clinical research programs within the Pediatric Pulmonary Division focus on multiple areas including research in childhood sleep disorders, infant apnea, infant pulmonary function testing, asthma, aerosol medicine, cystic fibrosis, control of breathing and postnatal development of oxygen sensing.

2024 Outcomes

By the Numbers

• 100% of children ages 7-17 met treatment guidelines for CF patients
• 457 unique patients with a diagnosis of rare lung disease were seen at least once in the inpatient or outpatient setting by the pediatric pulmonology program in the last year
• 99% of eligible patients with neuromuscular weakness disorders had pulmonary function testing in the last 12 months
• 100.3% is the median FEV1 for CF patients ages 6-12 years of age
• 104.5% is the median FEV1 for CF patients ages 13-17 years of age

Awards and Achievements

• Ranked number 29 by U.S. News & World Report
• Awarded five-year Cystic Fibrosis (CF) Center reaccreditation by the National Cystic Fibrosis Foundation
• One of the nation's largest pediatric respiratory therapy departments
• APEX Recognition by the American Association for Respiratory Care
• Creation of emergency-use albuterol action plans for school nurses across Arkansas, with support from the Arkansas Chapter of the American Academy of Pediatrics (AAP), American Academy of Family Physicians (AAFP) and Arkansas Medical Society (AMS)

Your Visit